date:Apr 17, 2014
gredients division, while investment in RD and process, based on its Optipep hydrolysed whey technology, resulted in a range of new products being brought to market during the year. These new products were targeted to the infant formula and clinical nutrition sectors.
Carbery also made significant investments in new infrastructure and partnerships internationally.
In 2012 the Group entered into a joint venture in Southern Brazil, with local multinational, BRF, to build and run a new whey proce